John Libbey Eurotext

European Journal of Dermatology

MENU

Topical rapamycin (sirolimus) for treatment of cutaneous microcystic lymphatic malformation of the gluteal area Volume 29, numéro 1, January-February 2019

Illustrations

  • Figure 1
Auteurs
1 University Hospital of Tours,
Department of Dermatology,
Unit of Pediatric Dermatology,
Center of Reference of Cutaneous Vascular Malformations (MAGEC),
Tours,
France
2 University Hospital of Angers,
Department of Pharmacy,
Angers,
France
3 University Hospital of Angers,
Department of Infectious and Tropical Diseases,
Angers,
France
4 University Hospital of Angers,
Department of Dermatology,
Angers,
France

Cutaneous microcystic lymphatic malformations (CMLMs) are rare conditions that result from abnormal embryological development of lymphatic vessels [1]. They present as clusters of vesicles that are full of lymph and blood. CMLMs commonly affect the lower limbs, gluteal areas, or the head and neck. The most frequent complications are oozing, bleeding, aesthetic impairment, pain, or bacterial infections. The management is challenging. Treatment options include surgery, laser therapy (carbon dioxide [...]